Sleep Medicine Reviews
Volume 5, Issue 2 , Pages 139-153 , April 2001

The duality of sleeping sickness: focusing on sleep

References 

  1. Dumas, M, Bouteille, B, Buguet, A (eds), Progress in Human African Trypanosomiasis, Sleeping Sickness. Paris: Springer Verlag 1999
  2. World Health Organisation, Control and Surveillance of African Trypanosomiasis. Report of a WHO Expert Committee. Technical Report Series No. 881. Geneva, Switzerland 1998; 114
  3. Stevens JR, Gibson W. The molecular evolution of trypanosomes. Parasitol Today. 1999;15:432–437
  4. Gibson, W, Stevens, J, Truc, P, Identification of trypanosomes: from morphology to molecular biology, In Dumas M, Bouteille B, Buguet A (eds) Progress in Human African Trypanosomiasis, Sleeping Sickness. Paris: Springer Verlag 1999; 7–29
  5. Lorenz P, Betschart B, Owen JS. Trypanosoma brucei brucei and high-density lipoproteins: old and new thoughts on the identity and mechanism of the trypanocidal factor in human serum. Parasitol Today. 1995;11:348–352
  6. Raper J, Nussenzweig V, Tomlinson S. The main lytic factor of Trypanosoma brucei brucei in normal human serum is not high-density lipoprotein. J Exp Med. 1996;183:1023–1029
  7. Bouteille, B, Dumas, M, Human African Trypanosomiasis: Sleeping Sickness, In Chopra JS, ÍSawhnney IMS (eds) Neurology in Tropics. New Delhi: B.I. Churchill Livingstone Pvt Ltd 1999; 324–336
  8. Hide G. History of sleeping sickness in East Africa. Clin Microbiol Rev. 1999;12:112–125
  9. Matthews KR. Developments in the differentiation of Trypanosoma brucei. Parasitol Today. 1999;15:76–80
  10. Pays, E, Antigenic variation in African trypanosomes, In Dumas M, Bouteille B, Buguet A (eds) Progress in Human African Trypanosomiasis, Sleeping Sickness. Paris: Springer Verlag 1999; 31–52
  11. Wéry M, Burke J. Human ««healthy carriers»» of Trypanosoma ( brucei type) discovered by immunofluorescence test in the République démocratique du Congo. Ann Soc Belge Méd Trop. 1970;50:613
  12. Frézil, JL, ««Trypanosomiasis exists when it is searched for.»» In Dumas M, Bouteille B, Buguet A (eds) Progress in Human African Trypanosomiasis, Sleeping Sickness. Paris: Springer Verlag 1999; 1–5
  13. Molyneux, DH, Ashford, RW, The Biology of Trypanosoma and Leishmania, Parasites of Man and Domestic Animals. London: Taylor and Francis 1983
  14. Jamot E. Etat sanitaire et dépopulation au Congo. Bull Soc Pathol Ex. 1920;13:127–138
  15. Jamot, E, Rapport de mission au Médecin général inspecteur des services sanitaires de l»AOF, 1933
  16. Stanghellini, A, Prophylactic strategies in human African trypanosomiasis, In Dumas M, Bouteille B, Buguet A (eds) Progress in Human African Trypanosomiasis, Sleeping Sickness. Paris: Springer Verlag 1999; 301–313
  17. Van Meirvenne, N, Biological diagnosis of human African trypanosomiasis, In Dumas M, Bouteille B, Buguet A (eds) Progress in Human African Trypanosomiasis, Sleeping Sickness. Paris: Springer Verlag 1999; 235–252
  18. Magnus E, Vervoort T, Van Meirvenne N. A card-agglutination test with stained trypanosomes (CATT) for the serological diagnosis of T b gambiense trypanosomiasis. Ann Soc Belge Méd Trop. 1978;58:169–176
  19. Bertrand I, Banlet J, Sicé . Lésions histologiques des centres nerveux dans la trypanosomiase humaine. Ann Inst Pasteur. 1935;54:91–144
  20. Poltera AA. Pathology of human African trypanosomiasis with reference to experimental African trypanosomiasis and infections of the central nervous system. Brit Med Bull. 1985;41:169–174
  21. Van Bogaert L, Janssen P. Contribution à l»étude de la neurologie et neuropathologie de la try- panosomiase humaine. Ann Soc Belge Méd Trop. 1957;37:379–426
  22. Adams JH, Haller L, Boa FY, Doua F, Dago A, Konian K. Human African trypanosomiasis ( T b gambiense): a study of 16 fatal cases of sleeping sickness with some observations on acute reactive arsenical encephalopathy. Neuropath Appl Neurobiol. 1986;12:81–94
  23. Rhind, SG, Shek, PN, Cytokines in the pathogenesis of human African trypanosomiasis: antagonistic roles of TNF- α and IL-10, In Dumas M, Bouteille B, Buguet A (eds) Progress in Human African Trypanosomiasis, Sleeping Sickness. Paris: Springer Verlag 1999; 119–135
  24. Mansfield, JM, Immunology of African trypanosomiasis, In Wyler DJ (eds) Modern Parasite Biology. New York: W.H. Freeman 1990; 222–246
  25. Okomo-Assoumou, MC, Mécanismes autoimmuns et perturbations du réseau des cytokines dans la physiopathologie de la trypanosomose humaine africaine. Bordeaux: Science doctorate dissertation, dactyl1995
  26. Bakhiet M, Olsson T, Ljungdahl Å, Höjeberg B, van der Meide P, Kristensson K. Induction of interferon- γ, transforming growth factor- β, and interleukin-4 in mouse strains with different susceptibilities to Trypanosoma brucei brucei. J Interfer Cytok Res. 1996;16:427–433
  27. Borst P, Fairlamb AH. Surface receptors and transporters of Trypanosoma brucei. Annu Rev Microbiol. 1998;52:745–778
  28. MacLean L, Odiit M, Okitoi D, Sternberg JM. Plasma nitrate and interferon-gamma in Trypanosoma brucei rhodesiense infections: evidence that nitric oxide production is induced during both early blood-stage and late meningoencephalitic-stage infections. Trans Roy Soc Trop Med Hyg. 1999;93:169–170
  29. Burlet S, Cespuglio R. Voltammetric detection of nitric oxide (NO) in the rat brain: its variations throughout the sleep-wake cycle. Neurosci Lett. 1997;226:131–135
  30. Buguet A, Burlet S, Auzelle F, Montmayeur A, Jouvet M, Cespuglio R. Dualité d»action du monoxyde d»azote dans la trypanosomose africaine expérimentale. CR Acad Sci Paris. 1996;319:201–207
  31. Banzet, S, Monoxyde d»azote et maladie du sommeil. Lyon: Medical doctoral dissertation, dactyl1997
  32. Rhind SG, Sabiston BH, Shek PN, Buguet A, Muanga G, Stanghellini A, et al. Effect of melarsoprol treatment on circulating IL-10 and TNF- α levels in human African trypanosomiasis. Clin Immunol Immunopathol. 1997;83:185–189
  33. Gobert AP, Daulouède S, Lepoivre M. L-arginine availability modulates local nitric oxide production and parasite killing in experimental trypanosomiasis. Infect Immun. 2000;68:4653–4657
  34. Gobert AP, Semballa S, Daulouede S, Lesthelle S, Taxile M, Veyret B, et al. Murine macrophages use oxygen- and nitric oxide-dependent mechanisms to synthesize S-nitroso-albumin and to kill extracellular trypanosomes. Infect Immun. 1998;66:4068–4072
  35. Kaushik RS, Uzonna JE, Gordon JR, Tabel H. Innate resistance to Trypanosoma congolense infections: differential production of nitric oxide by macrophages from susceptible BALB/c and resistant C57Bl/6 mice. Exp Parasitol. 1999;92:131–143
  36. Schleifer KW, Mansfield JM. Suppressor macrophages in African trypanosomiasis inhibit T cell proliferative responses by nitric oxide and protaglandins. J Immunol. 1993;151:5492–5503
  37. Jacobs P, Radzioch D, Stevenson MM. Nitric oxide expression in the spleen, but not in the liver, correlates with resistance to blood-stage malaria in mice. J Immunol. 1995;155:5306–5311
  38. Magez S, Radwanska M, Beschin A, Sekikawa K, De Baetselier P. Tumor necrosis factor alpha is a key mediator in the regulation of experimental Trypanosoma brucei infections. Infect Immun. 1999;67:3128–3132
  39. Rouzer CA, Cerami A. Hypertriglyceridemia associated with Trypanosoma brucei brucei infection in rabbits: role of defective triglyceride removal. Mol Biochem Parasitol. 1980;2:31–38
  40. Okomo-Assoumou MC, Geffard M, Daulouède S, Chaugier C, Lemesre JL, Vincendeau P. Circulating antibodies directed against tryptophan-like epitopes in sera of patients with human African trypanosomiasis. Am J Trop Med Hyg. 1995;52:461–467
  41. Reincke M, Arlt W, Heppner C, Petzke F, Chrousos GP, Allolio B. Neuroendocrine dysfunction in African trypanosomiasis. The role of cytokines. Ann N Y Acad Sci. 1998;840:809–821
  42. Radomski, MW, Brandenberger, G, Hormones in human African trypanosomiasis, In Dumas M, Bouteille B and Buguet A (eds) Progress in Human African Trypanosomiasis, Sleeping Sickness. Paris: Springer Verlag 1999; 183–190
  43. Keita M, Bouteille B, Enanga B, Vallat JM, Dumas M. Trypanosoma brucei brucei: a long-term model of human African trypanosomiasis in mice, meningo-encephalitis, astrocytosis, and neurological disorders. Exp Parasitol. 1997;85:183–192
  44. Keita, M, Etudes histologiques et immunohistologiques de l»évolution de la pathologie du système nerveux central au cours de la trypanosomose humaine africaine. Limoges: Science doctorate dissertation, dactyl1999
  45. Hunter CA, Jennings FW, Kennedy PGE, Murray M. Astrocyte activation correlates with cytokine production in central nervous system of Try- panosoma brucei brucei-infected mice. Lab Invest. 1992;67:635–642
  46. Keita M, Vincendeau P, Cespuglio R, Buguet A, Vallat JM, Dumas M, et al. Inducible nitric oxide synthase and nitrotyrosine in the central nervous system of mice chronically infected by Trypanosoma brucei brucei. Exp Parasitol. 2000;95:19–27
  47. Quan N, Mhlanga JDM, Whiteside MB, McCoy AN, Kristensson K, Herkenham M. Chronic overexpression of proinflammatory cytokines and histopathology of the brains of rats infected with Trypanosoma brucei. J Compar Neurol. 1999;414:114–130
  48. Vincendeau P, Daulouède S, Veyret B, Dardé ML, Bouteille B, Lemesre JL. Nitric oxide-mediated Ícytostatic activity on Trypanosoma brucei gambiense and Trypanosoma brucei brucei. Exp Parasitol. 1992;75:353–360
  49. Lapeyssonnie, Moi, Jamot. Le vainqueur de la maladie du sommeil. Musin L (ed.). Les Presses de l»INAM, 1987
  50. Challier A, Laveissière C. Un nouveau piège pour la capture des glossines ( Glossina: Diptera, Muscidae): description et essais sur le terrain. Cah ORSTOM Série Entomol Méd Parasitol. 1973;11:251–262
  51. Laveissière, C, Les glossines vectrices de la trypanosomiase africaine. Biologie et contrôle. WHO/UBC/88, 1988; doc no 958
  52. Maclennan, KJR, Practical application of measures for the control of tsetse-borne trypanosomiases of livestock, In Mulligan HW, Potts WH, Kershaw WE (eds) The African Trypanosomiases. Bath: Pitman Press 1970; 799–821
  53. Van Nieuwenhove, S, Present strategies in the treatment of human African trypanosomiasis, In Dumas M, Bouteille B, Buguet A (eds) Progress in Human African Trypanosomiasis, Sleeping Sickness. Paris: Springer Verlag 1999; 253–280
  54. Burri C, Nkunku S, Merolle A, Smith T, Blum J, Brun R. Efficacy of new, concise schedule for melarsoprol in treatment of sleeping sickness caused by Trypanosoma brucei gambiense: a randomised trial. Lancet. 2000;355:1419–1425
  55. Dumas, M, Bisser, S, Clinical aspects of human African trypanosomiasis, In Dumas M, Bouteille B, Buguet A (eds) Progress in Human African Trypanosomiasis, Sleeping Sickness. Paris: Springer Verlag 1999; 215–233
  56. Manson-Bahr, P, Manson's Tropical Diseases. A Manual of Diseases of Warm Climates. London: Cassel, 1942
  57. Mackensie S. La maladie du sommeil en Afrique. Mercredi Méd. 1890;47:597–598
  58. Buguet A, Gati R, Sèvre JP, Develoux M, Bogui P, Lonsdorfer J. 24-hour polysomnographic evaluation in a patient with sleeping sickness. Electroenceph Clin Neurophysiol. 1989;72:178–471
  59. Rechtschaffen, A, Kales, A, A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. Washington, DC: NIH publications no 204, Public Health Service, US Govt Printing Office, 1968
  60. Buguet A, Bert J, Tapie P, Tabaraud F, Doua F, Lonsdorfer J, et al. Sleep–wake cycle in human African trypanosomiasis. J Clin Neurophysiol. 1993;10:190–196
  61. Buguet A, Tapie P, Bert J. Reversal of the sleep–wake cycle disorder of sleeping sickness after trypanosomicide treatment. J Sleep Res. 1999;8:225–235
  62. Adam K. Sleep is changed by blood sampling through an indwelling venous catheter. Sleep. 1982;5:154–158
  63. Buguet A. Is sleeping sickness a circadian disorder? The serotonergic hypothesis. Chronobiol Int. 1999;16:477–489
  64. Coindet, J, Debilly, G, Mouret, J, Role of the raphé nuclei: II. On sleep circadian organization in the rat. Rome: Third European Neuroscience Meeting, 1979
  65. Brandenberger G, Buguet A, Spiegel K, Stanghellini A, Muanga G, Bogui P, et al. Disruption of endocrine rhythms in sleeping sickness with preserved relationship between hormonal pulsatility and the REM-NREM sleep cycles. J Biol Rhythms. 1996;11:258–267
  66. Claustrat B, Buguet A, Geoffriau M, Bogui P, Mouanga G, Stanghellini A, et al. Plasma melatonin rhythm is maintained in human African trypanosomiasis. Neuroendocrinology. 1998;68:64–70
  67. Radomski MW, Buguet A, Doua F, Bogui P, Tapie P. Relationship of plasma growth hormone to slow-wave sleep in African sleeping sickness. NeuroÍendocrinology. 1996;63:393–396
  68. Buguet A, Vincendeau P, Bouteille B, Burlet S, Cespuglio R. Nitric oxide in murine malaria: divergent roles in blood and brain suggested by voltammetric measures. Trans Roy Soc Trop Med Hyg. 1999;93:663–664
  69. Willett, KC, Epizootiology of trypanosomiasis in livestock in East and Central Africa, In Mulligan HW, Potts WH, Kershaw WE (eds) The African Trypanosomiases. Bath: Pitman Press 1970; 766–773
  70. De Raadt, P, Jannin, J, International co-operation: past and present, In Dumas M, Bouteille B and Buguet A (eds) Progress in Human African Trypanosomiasis, Sleeping Sickness. Paris: Springer Verlag 1999; 314–333

☆ Correspondence should be addressed to: Alain Buguet, M.DPh.DInstitut de Médecine tropicale du service de santé des armées, Le Pharo, B.P. 46, 13998 Marseille Armées, France. Fax: +33 (0)4 9159 44 77; E-mail: a.buguet@free.fr

PII: S1087-0792(00)90130-8

doi: 10.1053/smrv.2000.0130

Sleep Medicine Reviews
Volume 5, Issue 2 , Pages 139-153 , April 2001

Article Tools